Announced details
Regenerative medicine and gene therapy; manufacturing process development for regenerative medical products for advanced or recurrent cervical cancer
The Company’s proposal was selected for an AMED open-call project, and a subsidy grant was approved.
National Research and Development Agency. Other information, including the location, representative, capital, year of establishment, and business description, is not disclosed.
This matter will have no impact on the Company’s consolidated results for the fiscal year ending March 2027. The formal subsidy amount is expected to be finalized after the fiscal year ending March 2027.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Manufacturing process development for TIL (tumor-infiltrating lymphocyte) regenerative medical products for advanced or recurrent cervical cancer |
| Counterparty | Japan Agency for Medical Research and Development (AMED) |
| Counterparty overview | National Research and Development Agency. Other information, including the location, representative, capital, year of establishment, and business description, is not disclosed. |
| Relationship with the Company | The Company’s proposal was selected for an AMED open-call project, and a subsidy grant was approved. |
| Launch date | 14 September 2026 (start date of the subsidy project period; actual) |
| Applicable area | Regenerative medicine and gene therapy; manufacturing process development for regenerative medical products for advanced or recurrent cervical cancer |
| Impact on Business Performance | This matter will have no impact on the Company’s consolidated results for the fiscal year ending March 2027. The formal subsidy amount is expected to be finalized after the fiscal year ending March 2027. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company received a notification from AMED of the decision to award a subsidy for this project, which was selected for an AMED open-call project. The final subsidy amount and the timing of its recognition will be determined in AMED’s notification confirming the subsidy amount.